No.

Publication Date

Citing Article

1

2024

Mohsen Sheykhhasan, Anita S. La'ah, Amirhossein Ahmadieh-Yazdi, Hamid Tanzadehpanah, Hanie Mahaki, Hamed Manoochehri, Piao Yang, Naresh Poondla, Naser Kalhor, Sharafaldin Al-Musawi. 2024; 205.  https://doi.org/10.4018/979-8-3693-3976-3.ch006

2

2026

Chiara Vitale, Alessia Ruiba, Alessandra Dondero, Martina Serra, Alice Tassistro, Cristina Bottino, Roberta Castriconi. Advancements and Challenges in Mouse Models for NK Cell-Based Cancer Immunotherapy, Cancers. 2026; 18: 384.  https://doi.org/10.3390/cancers18030384

3

2026

Linlin Che, Xueting Xie, Xiaoyu Yang, Shiguo Zhu, Yufu Zhou. Natural Killer Cell‐Based Immunotherapy in HCC, Immunology. 2026; 178: 615.  https://doi.org/10.1111/imm.70141

4

2026

Saeed Mobini, Milad Chizari, Elham Rismani, Mohammadjavad Sadrzadeh, Arezoo Khosravi, Ali Zarrabi, Massoud Vosough. Pharmacological targeting of Fc receptor and FcRn pathways: Therapeutic antibody engineering in immune-mediated disorders, European Journal of Pharmacology. 2026; 1038: 179461179461.  https://doi.org/10.1016/j.ejphar.2026.179461

5

2025

Mengqi Yu, J. Xiao, L. Wang, Q. Liang. Current status and challenges of CAR-T cell therapy in the treatment of haematological cancer, BIO Web of Conferences. 2025; 182: 02001.  https://doi.org/10.1051/bioconf/202518202001

6

2025

Wenxue Ma, Sheldon Morris, Catriona Jamieson. Reprogramming natural killer cells in the tumor microenvironment: Challenges and therapeutic opportunities, Cytokine & Growth Factor Reviews. 2025; 86: 71.  https://doi.org/10.1016/j.cytogfr.2025.10.001

7

2026

Kaaviyaa Muthughavi, Manoj Khokhar, Hem Chandra Jha, Rajan Kumar Pandey. T-cell engagers in cancer immunotherapy: mechanisms, challenges, and future perspectives, Frontiers in Immunology. 2026; 17: 1755512.  https://doi.org/10.3389/fimmu.2026.1755512

8

2026

Ulrich Brinkmann, Roland E. Kontermann. The making of multispecific immunoglobulins – a clinical perspective, mAbs. 2026; 18: 2613548.  https://doi.org/10.1080/19420862.2026.2613548

9

2025

Kyung-Nam Koh, Dae Hee Kim, Hyori Kim. Trispecific T cell engagers in hematological malignancies: Advancing beyond bispecific antibodies, Seminars in Hematology. 2025; 62: 350.  https://doi.org/10.1053/j.seminhematol.2025.11.002

10

2026

Jorge Fernández Pérez, Risa Asano, Yuta Uto, Kouhei Tsumoto, Makoto Nakakido. 2026; 201.  https://doi.org/10.1016/B978-0-443-29808-0.00069-8

11

2026

Sarra Mestiri, Laila Assami, Zeenath Safira K. M. Yoosuf, Queenie Fernandes, Dina Moustafa Abo El-Ella, Hesham Elsabah, Maysaloun Merhi, Karama Makni-Maalej, Honar Cherif, Said Dermime, Shahab Uddin, Fares Al-Ejeh. Emerging precision medicine in multiple myeloma: clinical and preclinical landscape of T cell, natural killer cell, and macrophages engaging multi-specific antibodies, Frontiers in Immunology. 2026; 17: 1822508.  https://doi.org/10.3389/fimmu.2026.1822508

12

2025

B. Monchusi, P. Dube, M. M. Takundwa, V. L. Kenmogne, T. Malise, D. B. Thimiri Govinda Raj. 2025; 1488: 161.  https://doi.org/10.1007/5584_2025_863

13

2026

Xinyang Liu, Xinyi Fan, Yihuan Wang, Lili Wang, Dehao Lu, Yuhui Wang, Xiangzheng Meng, Leli Fan, Wenjing Zhu, Xinlin Liu, Li Ye, Peng Sun. Trispecific antibodies in cancer therapy: Mechanisms, clinical progress and future directions, International Immunopharmacology. 2026; 177: 116503116503.  https://doi.org/10.1016/j.intimp.2026.116503